武田制药(TAK)股吧_武田制药怎么样_分析讨论社区

列表
摘要

发新帖

发表新帖
问董秘
发起斗股

阅读	评论	标题	作者	最后更新
164	0	跨国巨头“瘦身”换挡，豪赌百亿美元新药胜算几何？	武田制药资讯	05-27 05:02
34	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	武田制药资讯	05-26 06:18
32	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	武田制药资讯	05-26 06:16
30	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	武田制药资讯	05-26 06:14
31	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	武田制药资讯	05-26 06:14
29	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	武田制药资讯	05-26 06:14
223	2	赔170亿、裁4500人、官司缠身！亚洲最大药企的“至暗一周”	E药经理人	05-21 09:47
1581	0	武田制药反垄断败诉面临最高约25亿美元天价赔偿武田：将积极寻求审判后动议和上诉	武田制药资讯	05-25 01:44
39	0	Specialized disclosure report	武田制药资讯	05-22 11:29
33	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	武田制药资讯	05-19 06:12
1106	2	武田制药将裁员约4500人	武田制药资讯	05-14 12:26
210	0	武田制药将全球裁员4500人，占员工总数的10%	武田制药资讯	05-14 04:08
85	0	【武田制药将裁员约4500人】日本制药公司武田制药在其发布的2025财年业绩报告	首席消费官	05-14 03:26
98	0	武田制药将裁员约4500人	格隆汇	05-14 12:27
147	0	武田制药大裁员	武田制药资讯	05-14 12:00
39	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	武田制药资讯	05-13 06:16
38	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	武田制药资讯	05-13 06:11
300	1	第二十四篇:研发费用，决定企业未来的成长底线	现流深耕	05-12 04:13
201	0	第二十篇:投资活动现金流净额：看清企业扩张野心与生死退路	现流深耕	05-10 09:23
848	1	信达生物2025年全面盈利，营收首破百亿，跻身全球制药第一梯队!	摩熵医药	05-08 02:57
45	0	Initial statement of beneficial ownership of securities	武田制药资讯	05-05 06:36
41	0	Statement of changes in beneficial ownership of securities	武田制药资讯	04-28 06:16
43	0	Statement of changes in beneficial ownership of securities	武田制药资讯	04-28 06:16
48	0	Statement of changes in beneficial ownership of securities	武田制药资讯	04-28 06:16
37	0	Statement of changes in beneficial ownership of securities	武田制药资讯	04-28 06:16
41	0	Statement of changes in beneficial ownership of securities	武田制药资讯	04-28 06:16
37	0	Statement of changes in beneficial ownership of securities	武田制药资讯	04-28 06:16
45	0	Statement of changes in beneficial ownership of securities	武田制药资讯	04-28 06:16
42	0	Statement of changes in beneficial ownership of securities	武田制药资讯	04-28 06:16
41	0	Statement of changes in beneficial ownership of securities	武田制药资讯	04-28 06:16
42	0	浙一明天10个np请马上拉升	凤起潮鸣123	04-20 10:36
63	0	Initial statement of beneficial ownership of securities	武田制药资讯	04-06 06:28
63	0	Initial statement of beneficial ownership of securities	武田制药资讯	04-06 06:25
65	0	Initial statement of beneficial ownership of securities	武田制药资讯	04-06 06:22
330	0	“为外企在华深耕筑牢了确定性根基”——在华跨国企业看好“十五五”时期中国经济发展	武田制药资讯	03-31 06:29
67	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	武田制药资讯	03-30 06:33
1939	0	武田制药：过半Zasocitinib治疗的银屑病患者16周皮损完全或几乎完全清除	武田制药资讯	03-30 02:51
78	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	武田制药资讯	03-26 06:09
68	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	武田制药资讯	03-25 06:09
736	2	科伦药业新动态：伏硫西汀滴剂上市申请获受理，抑郁症管线迎来重磅拼图！	摩熵医药	03-23 04:20
839	0	国产TYK2抑制剂战局再添一员：文达医药WD-890启动III期，剑指诺诚健华与益方生物	摩熵医药	03-19 04:47
66	0	Initial statement of beneficial ownership of securities	武田制药资讯	03-18 11:31
59	0	Initial statement of beneficial ownership of securities	武田制药资讯	03-18 11:31
61	0	Initial statement of beneficial ownership of securities	武田制药资讯	03-18 11:31
58	0	Initial statement of beneficial ownership of securities	武田制药资讯	03-18 11:31
55	0	Initial statement of beneficial ownership of securities	武田制药资讯	03-18 11:30
54	0	Initial statement of beneficial ownership of securities	武田制药资讯	03-18 10:10
54	0	Initial statement of beneficial ownership of securities	武田制药资讯	03-18 10:10
57	0	Initial statement of beneficial ownership of securities	武田制药资讯	03-18 10:10
56	0	Initial statement of beneficial ownership of securities	武田制药资讯	03-18 10:10
54	0	Initial statement of beneficial ownership of securities	武田制药资讯	03-18 10:10
60	0	Initial statement of beneficial ownership of securities	武田制药资讯	03-18 09:27
59	0	Initial statement of beneficial ownership of securities	武田制药资讯	03-18 09:27
61	0	Initial statement of beneficial ownership of securities	武田制药资讯	03-18 09:27
62	0	Initial statement of beneficial ownership of securities	武田制药资讯	03-18 09:27
56	0	Initial statement of beneficial ownership of securities	武田制药资讯	03-18 09:27
57	0	Initial statement of beneficial ownership of securities	武田制药资讯	03-18 09:27
59	0	Initial statement of beneficial ownership of securities	武田制药资讯	03-18 09:27
58	0	Initial statement of beneficial ownership of securities	武田制药资讯	03-18 09:19
63	0	Initial statement of beneficial ownership of securities	武田制药资讯	03-18 09:01
60	0	Initial statement of beneficial ownership of securities	武田制药资讯	03-18 09:00
52	0	Initial statement of beneficial ownership of securities	武田制药资讯	03-18 09:00
55	0	Initial statement of beneficial ownership of securities	武田制药资讯	03-18 09:00
58	0	Initial statement of beneficial ownership of securities	武田制药资讯	03-18 09:00
63	0	Initial statement of beneficial ownership of securities	武田制药资讯	03-18 08:58
71	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	武田制药资讯	03-02 07:14
74	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	武田制药资讯	02-10 07:10
768	11	对标的日本血制品龙头，四季度业绩巨亏，股价创历史新高，达到3800亿，相当于36	一顿分析	02-02 10:28
369	0	刘燕博士正式担任武田中国总裁	武田制药资讯	01-30 11:24
260	0	武田制药任命刘燕为武田中国总裁	武田制药资讯	01-30 10:51
97	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	武田制药资讯	01-29 07:14
297	0	受尼帕疫情影响，日本静丙，血蛋白企业创历史新高。	一顿分析	01-28 12:07
319	0	武田制药(TAK.US)1类新药“奥博雷通片”在中国申报上市	智通财经	01-16 03:54
519	0	60亿美元豪赌见效！武田自免口服新药针对中重度斑块状银屑病3期数据积极拟明年向FDA提交上市申请	武田制药资讯	12-19 04:51
404	0	武田制药：银屑病新药Zasocitinib的3期临床成功	武田制药资讯	12-18 10:33
339	0	武田制药公布银屑病新药临床研究结果每日一次口服方案有望实现皮损清除	武田制药资讯	12-18 09:33
87	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	武田制药资讯	12-18 07:13
83	0	Report of proposed sale of securities	武田制药资讯	12-09 07:07
3060	15	2025医保、商保双目录公布：医保新增50种一类创新药，多款CAR-T、罕见病用药纳入商保	复星医药资讯	12-08 03:13
84	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	武田制药资讯	12-08 07:22

emytylist